Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Imeron
2. Iomeprol 350
3. Iomeprol 400
4. Iomeron
1. 78649-41-9
2. Iomeprolum
3. Iomeron
4. Imeron
5. Iomeron 300
6. N,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(n-methylglycolamido)isophthalamide
7. N1,n3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-n-methylacetamido)-2,4,6-triiodoisophthalamide
8. E-7337
9. 1-n,3-n-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzene-1,3-dicarboxamide
10. 17e17jbp8l
11. 1185146-41-1
12. Chebi:31710
13. N,n'-bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide
14. Ncgc00183283-01
15. Iomeprolo
16. E7337
17. 1,3-benzenedicarboxamide, N,n'-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)methylamino)-2,4,6-triiodo-
18. Iomeprolum [inn-latin]
19. Unii-17e17jbp8l
20. Iomeprol [usan:inn:ban:jan]
21. Iomeprol [usan]
22. Iomeprol [inn]
23. Iomeprol [jan]
24. Iomeprol [mi]
25. Iomeron 300 (tn)
26. Iomeprol [mart.]
27. Iomeprol [who-dd]
28. Dsstox_cid_28987
29. Dsstox_rid_83252
30. Dsstox_gsid_49061
31. Schembl26981
32. Iomeprol (jan/usan/inn)
33. Chembl2107214
34. Dtxsid1049061
35. Bcp34386
36. Tox21_113611
37. Akos030255901
38. Db11705
39. Ac-30722
40. Cas-78649-41-9
41. Db-056324
42. Ft-0627277
43. Ft-0670399
44. Methylacetamido)-2,4,6-triiodoisophthalamide
45. D01719
46. Iomeprol 100 Microg/ml In Acetonitrile/methanol
47. Iomeprol 100 Microg/ml In Acetonitrile:methanol
48. A839467
49. B-16880
50. N1,n3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-n-
51. Q6062808
52. 1,3-benzenedicarboxamide, N1,n3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-
Molecular Weight | 777.1 g/mol |
---|---|
Molecular Formula | C17H22I3N3O8 |
XLogP3 | -2.3 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 10 |
Exact Mass | 776.8541 g/mol |
Monoisotopic Mass | 776.8541 g/mol |
Topological Polar Surface Area | 180 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 591 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V08AB10
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media
V08AB10 - Iomeprol
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
73
PharmaCompass offers a list of Iomeprol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Iomeprol manufacturer or Iomeprol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iomeprol manufacturer or Iomeprol supplier.
PharmaCompass also assists you with knowing the Iomeprol API Price utilized in the formulation of products. Iomeprol API Price is not always fixed or binding as the Iomeprol Price is obtained through a variety of data sources. The Iomeprol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_28987 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_28987, including repackagers and relabelers. The FDA regulates DSSTox_CID_28987 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_28987 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_28987 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_28987 supplier is an individual or a company that provides DSSTox_CID_28987 active pharmaceutical ingredient (API) or DSSTox_CID_28987 finished formulations upon request. The DSSTox_CID_28987 suppliers may include DSSTox_CID_28987 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_28987 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_CID_28987 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_28987 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_28987 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_28987 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DSSTox_CID_28987 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_28987 USDMF includes data on DSSTox_CID_28987's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_28987 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DSSTox_CID_28987 suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DSSTox_CID_28987 Drug Master File in Korea (DSSTox_CID_28987 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DSSTox_CID_28987. The MFDS reviews the DSSTox_CID_28987 KDMF as part of the drug registration process and uses the information provided in the DSSTox_CID_28987 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DSSTox_CID_28987 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DSSTox_CID_28987 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DSSTox_CID_28987 suppliers with KDMF on PharmaCompass.
DSSTox_CID_28987 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_28987 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_28987 GMP manufacturer or DSSTox_CID_28987 GMP API supplier for your needs.
A DSSTox_CID_28987 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_28987's compliance with DSSTox_CID_28987 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_28987 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_28987 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_28987 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_28987 EP), DSSTox_CID_28987 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_28987 USP).